Tag: Pharmagest
EQUASENS /Pharmagest – First-half 2022 revenue – 08/03/2022 at 6:00 p.m.
Growth of +10.3% to €103.57 million. – On a like-for-like basis (excluding the acquisition of PROKOV EDITIONS), the Group recorded growth of +7.68% to €101.11 million. Growth of all Divisions…
EQUASENS (formerly Pharmagest Interactive): RESULTS OF THE VOTE ON THE RESOLUTIONS PRESENTED TO THE ANNUAL ORDINARY GENERAL MEETING OF JUNE 28, 2022
Villers-lès-Nancy, July 6, 2022 – 7:00 p.m. (CET) PRESS RELEASE RESULTS OF THE VOTE ON THE RESOLUTIONS PRESENTEDTO THE ORDINARY ANNUAL GENERAL MEETING FROM 28 JUNE 2022 Number of shares…
EQUASENS / Pharmagest – Notice of meeting of AGM of June 28, 2022 – Methods of making preparatory documents available – 06/10/2022 at 6:51 p.m.
The company EQUASENS (formerly called PHARMAGEST INTERACTIVE) invites its shareholders to participate in the Annual Ordinary General Meeting which will meet on Tuesday June 28, 2022, at 5 p.m., at…
Pharmagest inter. : Ségur referencing obtained for MédiStory 4
Receive the value of the day selected by The data collected is essential for this processing and is intended for the relevant departments of BFM Bourse and, where applicable, its…
EQUASENS / Pharmagest – MédiStory 4, First doctor’s software referenced Ségur – 06/03/2022 at 18:12
PROKOV Editions, a subsidiary of the Equasens Group, (Euronext Paris – compartment A – Isin: FR 0012882389) is the publisher of the medical practice management software MédiStory, leading software in…
EQUASENS / Pharmagest – Prior notice AGM June 28, 2022 – 05/30/2022 at 6:01 p.m.
The company EQUASENS (formerly called PHARMAGEST INTERACTIVE) invites its shareholders to participate in the Annual Ordinary General Meeting which will meet on Tuesday June 28, 2022, at 5 p.m., at…
EQUASENS/ Pharmagest – Q1 2022 sales: +9.03% to €49.36m – 05/12/2022 at 6:10 p.m.
Q1 2022 revenue: +9.03% to €49.36m Effective change of name: the Pharmagest Group becomes the Equasens Group • The Extraordinary General Meeting of May 6, 2022 adopted the resolution to…
Pharmagest Interactive becomes Equasens
By Alexandra Saintpierre Published on 05/10/2022 at 2:55 p.m. Photo credit © Pharmagest …
Solid profits and soon a new name for Pharmagest
Subscribe for 1€ Unlimited access to all advice More than 800 stocks listed in Paris and abroad screened. To buy ? To sell ? What course objective? Our experts engage…
Pharmagest – 2021 Net Income: +25.97% to €41.15m and name change project – 03/25/2022 at 7:20 p.m.
• Solid progress in results:o Operating profit: +8.95% to €50.26 million.o Net profit: +25.97% to €41.15 million.o Basic Earnings per Share: +27.78% to €2.60. • Dividend proposed for the 2021…
Pharmagest: growth of more than 12% in turnover in 2021
(CercleFinance.com) – Pharmagest Interactive publishes a turnover for 2021 up 12.4% to 193.1 million euros, including +12.2% to 142.9 million for its Europe pharmacy solutions division with a significant contribution…
Pharmagest: turnover growth of more than 12% in 2021 – 02/07/2022 at 07:43
(CercleFinance.com) – Pharmagest Interactive publishes a turnover for 2021 up 12.4% to 193.1 million euros, including +12.2% to 142.9 million for its Europe pharmacy solutions division with a significant contribution…